CLASS II ONGOING Device recall · Reported 24 Jan 2024 · FDA Enforcement Report

Vacuette Tube FX Sodium Fluoride/Potassium Oxalate recalled

Greiner Bio-One North America is recalling Vacuette Tube FX Sodium Fluoride/Potassium Oxalate, distributed nationwide in the US. The recall was initiated on 12 Dec 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #A221135N, Exp. date 03/02/2024, UDI-DI Case label 39120017575130, UDI Rack label 29120017575133.
Quantity recalled495,600 tubes

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0733-2024
FDA event ID
93606
Recalling firm
Greiner Bio-One North America, Monroe, NC
Classification
Class II
Status
Ongoing
Recall initiated
12 Dec 2023
FDA classified
16 Jan 2024
Reported
24 Jan 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

12 Dec 2023Recall initiated by company
16 Jan 2024Classified by FDA+35 days
24 Jan 2024Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Tubes have missing additive/anticoagulant resulting in clotting in most cases. A completely clotted sample would lead to no results being reported, which could lead to a delay in treatment or diagnosis. An erroneous glucose or lactose result from a partially clotted sample could lead to inappropriate treatment.

Product as listed by the FDA

VACUETTE TUBE 4 ml FX Sodium Fluoride/Potassium Oxalate, Item #454297, 13x75 grey cap-black ring, non-ridged.

Where it was distributed

US Nationwide distribution in the states of CT, FL, IA, IL, MO, NC, NY, PA, TN, and VA.

Nationwide ConnecticutFloridaIowaIllinoisMissouriNorth CarolinaNew YorkPennsylvaniaTennesseeVirginia

Questions about this recall

Why was it recalled?

Tubes have missing additive/anticoagulant resulting in clotting in most cases. A completely clotted sample would lead to no results being reported, which could lead to a delay in treatment or diagnosis. An erroneous glucose or lactose result from a partially clotted sample could lead to inappropriate treatment.

Which lots are affected?

Lot #A221135N, Exp. date 03/02/2024, UDI-DI Case label 39120017575130, UDI Rack label 29120017575133.

Where was it sold?

US Nationwide distribution in the states of CT, FL, IA, IL, MO, NC, NY, PA, TN, and VA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Greiner Bio-One North America

All 17

Other Other Medical Devices recalls

All 13,968